These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4134872)

  • 1. Immunological heterogeneity of Clostridium botulinum type B toxins.
    Shimizu T; Kondo H; Sakaguchi G
    Jpn J Med Sci Biol; 1974 Apr; 27(2):99-100. PubMed ID: 4134872
    [No Abstract]   [Full Text] [Related]  

  • 2. Study on the immunological heterogeneity of Clostridium botulinum B type toxin.
    Rymkiewicz D; Sawicki J; Brühl A
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):709-14. PubMed ID: 398207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antigenicity of Clostridium botulinum type C toxin administered per os.
    Jansen BC; Knoetze PC; Visser F
    Onderstepoort J Vet Res; 1970 Sep; 37(3):169-71. PubMed ID: 4949136
    [No Abstract]   [Full Text] [Related]  

  • 4. The toxic antigenic factors produced by Clostridium botulinum types C and D.
    Jansen BC
    Onderstepoort J Vet Res; 1971 Jun; 38(2):93-8. PubMed ID: 4950122
    [No Abstract]   [Full Text] [Related]  

  • 5. [Induction and modulation of humoral immunity in mice by local nasal administration of botulinum toxoid type B].
    Hörmeyer E; Schultz A; Sailer J; Opitz G; Stünkel K; Petzoldt K
    Berl Munch Tierarztl Wochenschr; 1985 Jan; 98(1):16-9. PubMed ID: 3885940
    [No Abstract]   [Full Text] [Related]  

  • 6. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of strain B 657 of Clostridium botulinum].
    Giménez DF; Giménez JA
    Rev Argent Microbiol; 1983; 15(1):51-5. PubMed ID: 6400761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitoxin responses to Clostridium botulinum vaccines types C and D in guinea pigs.
    Mathews AG
    Dev Biol Stand; 1976; 32():193-201. PubMed ID: 793915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON; Ciccarelli AS; Giménez DF
    Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships of leukocyte metabolism to Clostridium botulinum pathogenicity.
    Suzuki JB; Benedik A; Grecz N
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):633-48. PubMed ID: 4945072
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of type E botulinal toxin in cultures by fluorescent-antibody microscopy.
    Aalvik B; Sakaguchi G; Riemann H
    Appl Microbiol; 1973 Jan; 25(1):153-4. PubMed ID: 4568886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M; Bitar RA; Bartlett JG
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cultural and physiological characteristics of Clostridium botulinum type G and the susceptibility of certain animals to its toxin.
    Ciccarelli AS; Whaley DN; McCroskey LM; Gimenez DF; Dowell VR; Hatheway CL
    Appl Environ Microbiol; 1977 Dec; 34(6):843-8. PubMed ID: 74236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serological study of Clostridium botulinum type A and strain 84 toxins].
    Ciccarelli AS; Giménez DF
    Rev Latinoam Microbiol; 1971; 13(2):67-74. PubMed ID: 4941891
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An international survey of clostridial sera and vaccines.
    Davidson I
    Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of soluble antigens of Clostridium botulinum A by chemiluminescent--immunosorbent assay (CLISA).
    Ligieza J; Michalik M; Reiss J; Grzybowski J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):189-95. PubMed ID: 2431667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins.
    Simpson LL
    J Pharmacol Exp Ther; 1982 Dec; 223(3):695-701. PubMed ID: 6292397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.